Biotechnological Production of 2′-Fucosyllactose: A Prevalent Fucosylated Human Milk Oligosaccharide

Wenting Zhou,Hong Jiang,Lili Wang,Xingxing Liang,Xiangzhao Mao
DOI: https://doi.org/10.1021/acssynbio.0c00645
IF: 5.249
2021-03-09
ACS Synthetic Biology
Abstract:Human milk oligosaccharide (HMO) is a key component of human milk carbohydrates and is closely related to the nutrition and health benefits of breastfeeding in infants. 2′-Fucosyllactose (2′-FL) is the most abundant fucosylated HMO, which has remarkable value in nutrition and medicine, such as suppressing pathogen infection, regulating intestinal flora, and boosting immunity. However, 2′-FL production via the method of extraction or chemical synthesis cannot meet its large demand, and as a result, environmentally friendly and efficient biotechnological approaches, including <i>in vitro</i> enzymatic synthesis and microbial cell factory production, have been developed and applied to its commercialized production. This review introduces, summarizes, and discusses the recent advances in the biotechnological production of 2′-FL. Furthermore, future research directions for the biotechnological production of 2′-FL as well as the strategies to further improve its concentration are highlighted and discussed.This article has not yet been cited by other publications.
biochemical research methods
What problem does this paper attempt to address?